ArticleFrontiers in oncology2025
Histologic grade and STAS as key predictors of distant recurrence in resected early-stage lung adenocarcinoma: a single-center study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early-stage lung adenocarcinoma (ADC) is curable by surgical resection in most cases. However, unexpectedly, some patients experience distant disease relapse. Emerging evidence suggests that microscopic tumor characteristics may increase the risk of tumor relapse. Consequently, we aimed to test different microscopic variables to assess their association with distant recurrence (DR). Materials and methods: We retrieved all cases of radically treated stage I-IIA ADCs from 2016 to 2020. Clinical and pathological variables were assessed for their association with DR using univariable and multivariable logistic regression. An EGFR-adjusted model was also provided. Results: A total of 259 patients were treated (214 lobectomies and 45 segmentectomies). After resection, 54 patients relapsed, 28 of whom had distant recurrences (DR). Spread through air spaces (STAS) was detected in 48% of samples, while vascular invasion (VI) was present in 53%, occurring 17% more frequently in those with DR. Tumor size was larger in patients with recurrence, with the largest tumors observed in those with local recurrence (25.5 mm in local vs. 23.5 mm in DR; p=0.028). Dedifferentiated (G3) ADCs were more prevalent in DR cases, accounting for 48% of samples. In univariate regression, surgical margins, LVI, necrosis, G3 primary tumors, and STAS were significant factors. In multivariate analysis, STAS showed a trend towards significance (p=0.07) while G3 remained decisive (p<0.01). The EGFR-adjusted model for DR yielded slightly better results (p=0.05 and p<0.01 respectively). Conclusions: Dedifferentiation and partially STAS are key pathological predictor of distant recurrence in resected stage I-IIA ADCs. The contribution of LVI and tumor necrosis in DR needs to be further clarified. Tumor aggressiveness goes beyond the simple size measurement, claiming for a reassessment of risk models for recurrence after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.